
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India".
Filed with NSE · · 3 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals